NCPDP President & CEO Lee Ann Stember Plans to Retire After 46 Years of Transformative Leadership in Healthcare

Lee Ann Stember's Legacy: A Milestone in Healthcare Leadership

Lee Ann Stember, the President and CEO of the National Council for Prescription Drug Programs (NCPDP), has announced her upcoming retirement, set for June 1, 2027. After an inspiring 46-year career characterized by commitment and transformative leadership, Stember’s announcement comes as NCPDP looks forward to celebrating its 50th anniversary, marking a significant milestone in the organization’s journey.

Stember shared her retirement plans during the November Workgroup Meeting in Portland, communicating her decision to the organization’s Compensation Committee, Board of Trustees, and Executive Management Team. This moment marks a bittersweet transition, as Stember reflects on her journey. “NCPDP has been more than just a professional space for me; it has formed a community—an extraordinary opportunity to champion meaningful change in healthcare,” she expressed.

Throughout her extensive tenure, Stember has led NCPDP through profound advancements in healthcare technology, particularly in the realms of interoperability and health information exchange. Under her guidance, the organization emerged as a pivotal collaborator among diverse stakeholders, ensuring a unified approach toward developing standards that enhance patient care and reduce administrative complexities.

Stember's mission has always emphasized the importance of patient access to their health information and fostering seamless collaboration among healthcare professionals.